Sansure Biotech Inc Financial Flexibility Index
Sansure Biotech Inc financial flexibility index. Sansure Biotech Inc (688289) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥122.80 Million (operating CF CN¥59.72 Million minus capex CN¥63.08 Million) represents 0% of total liabilities (CN¥2.24 Billion). Explore Sansure Biotech Inc (688289) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sansure Biotech Inc (2017–2024)
Financial flexibility index of Sansure Biotech Inc from 2017 to 2024. Historical Financial Flexibility Index trend for Sansure Biotech Inc across 8 annual periods. Check Sansure Biotech Inc (688289) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Sansure Biotech Inc Financial Flexibility Index by Year (2017–2024)
Sansure Biotech Inc financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Sansure Biotech Inc. For the full cash flow conversion analysis, see cash flow conversion of Sansure Biotech Inc.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | CN¥695.55 Million | CN¥274.45 Million | CN¥1.26 Billion | ▲ +12.9% |
| 2023 | 0.49x | CN¥504.17 Million | CN¥112.82 Million | CN¥1.03 Billion | ▼ -73.9% |
| 2022 | 1.88x | CN¥3.12 Billion | CN¥2.56 Billion | CN¥1.66 Billion | ▼ -40.8% |
| 2021 | 3.17x | CN¥2.25 Billion | CN¥1.88 Billion | CN¥709.03 Million | ▼ -18.2% |
| 2020 | 3.88x | CN¥2.75 Billion | CN¥2.64 Billion | CN¥708.95 Million | ▲ +483.2% |
| 2019 | 0.67x | CN¥56.55 Million | CN¥22.41 Million | CN¥84.99 Million | ▲ +141.2% |
| 2018 | 0.28x | CN¥42.97 Million | CN¥10.07 Million | CN¥155.76 Million | ▲ +226.3% |
| 2017 | -0.22x | CN¥-40.76 Million | CN¥-61.44 Million | CN¥186.62 Million | — |